AI-generated summary, not yet reviewed by Better Utah staff. Please consult the bill text.

Utah's "Right to Try" law allows seriously ill patients to access experimental drugs and medical devices that have passed initial FDA safety testing but haven't yet received full approval. This bill would expand that law by creating a new category called "eligible illness" — a severely debilitating or life-threatening condition where a doctor determines that conventional treatments offer no satisfactory or comparable option — so patients with serious but non-terminal conditions could also qualify for investigational treatments, provided the treatment is still undergoing an active FDA-regulated investigation. It would also broaden the definition of "terminal illness" to explicitly include cancer diagnosed by a board-certified oncologist, update the list of allowable drug forms to include any liquid formulation rather than only suspensions, and require manufacturers who provide investigational drugs or devices to Utah patients under the new "eligible illness" category to report annually to a legislative committee on how many patients were treated, what conditions were treated, and any adverse outcomes, unless those patients were already part of a formal clinical trial.